Battelle is a GLP-compliant, IND and BLA-enabling CRO. We provide services that can help move projects from in vitro to in vivo through clinical support. Specifically, our core capabilities are focused around our long-standing experience and expertise in cell-based and biochemical assay development, validation and analytical and bioanalytical sample screening, proteomics, compound synthesis, HTP next generation sequencing, in vivo efficacy, safety pharmacology, toxicology, inhalation toxicology (small and large species), ADME/PK, analytical chemistry, pathology.
Battelle also has deep experience developing and manufacturing medical devices, and in conjunction with customer test articles is able to validate both the device and test article together.